LEADER surveillance program results for 2006: An activity and spectrum of linezolid using clinical isolates from the United States (50 medical centers).

LEADER surveillance program results for 2006: An activity and spectrum of linezolid using clinical isolates from the United States (50 medical centers). by Jones RN, Fritsche TR, Sader HS and Ross JE published in Diagn. Microbiol. Infect. Dis. 2007; 59 (3): 309-317